Celltrion, Stock Price +0.5% at This Hour... 469,589 Shares Net Bought by Individuals in the Last 5 Days

As of 2:31 PM on the 2nd, Celltrion is trading at 299,500 KRW, up 0.5% from the previous day. The trading volume is 453,535 shares, which is 73.29% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On September 1st, Hana Financial Investment researchers Minjeong Seon and Seungwon Kang stated, "The fact that Celltrion's development and production items are biosimilars rather than new drugs raises clear concerns about maintaining continuous high growth and high margins. They are working on improving production yield through titer improvement, and through this, it is expected that even products released long ago, like Remsima, will continue to maintain high margins. Sustainable high growth through the launch of the 1st biosimilar." They set Celltrion's target price at 363,000 KRW.

Over the past five days, individual investors have net purchased 469,589 shares of Celltrion, while foreigners and institutions have net sold 384,804 shares and 87,716 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.